..............page:355-358
..............page:287-290
..............page:333-335
..............page:210-213
..............page:369-372
..............page:347-350
..............page:264-266,270
..............page:248-251
..............page:229-232
..............page:305-309
..............page:339-342
..............page:362-365
..............page:302-304
..............page:267-270
..............page:226-228,232
..............page:343-346,350
..............page:233-236
..............page:376-380
..............page:298-301
..............page:359-361
..............page:325-328
..............page:283-286
..............page:313-317
..............page:214-217
..............page:336-338
..............page:279-282
..............page:260-263
..............page:206-209,213
..............page:381-384
..............page:271-275
..............page:198-201
..............page:244-247
..............page:373-375
..............page:366-368
..............page:310-312,317
..............page:318-321
..............page:294-297
..............page:291-293,297
..............page:329-332
..............page:193-197
..............page:237-240
..............page:252-255
..............page:241-243,247
..............page:222-225
..............page:276-278
..............page:218-221
..............page:322-324
..............page:351-354
The study of PLGA nanoparticle surface modified with chitosan as protein drug carriers
CHEN Hong-li1;LV Jie-li2;YAN Jie3;WANG Yin-song4;GUO Wei-yun1; FENG Hui-gen1;CHEN Han3;ZHANG Qi-qing3; Department of Life Science and Technology;Xinxiang Medical University;Xinxiang 453003;China; 2.College of Pharmacy;Xinxiang Medical University;Xinxiang 453003;China; 3.Institute of Biomedical Engineering;Chinese Academy of Medical Science; Peking Union Medical College;Tianjin 300192;China; 4.College of Pharmacy;Tianjin Medical University;Tianjin 300070;China)
..............page:202-205
..............page:256-259,263